PRZOOM - /newswire/ -
Franklin Lakes, NJ, United States, 2010/10/01 - $38 million investment committed to 720,000sf state-of-art facility. Nearly 190 new jobs expected. NYSE: BDX
BD (Becton, Dickinson and Company), a leading global medical technology company, today announced plans to construct a new East Coast distribution center in Four Oaks, North Carolina. The $38 million investment project is expected to generate nearly 190 new jobs in Four Oaks and the surrounding communities by 2018.
“Establishing our new distribution center in Four Oaks will enable BD to reduce cycle times and enhance the operational effectiveness of our entire supply chain,” said Stephen Sichak, Senior Vice President, Integrated Supply Chain. “Additional benefits include the skilled work force, transportation infrastructure and supportive government officials in this region.”
The new 720,000-square foot facility, which will be constructed on 130 acres in the Four Oaks Business Park, will be expandable to more than 1.1 million square feet. It will service BD customers from Maine to Florida. Construction is expected to be completed in mid-2011, and the facility is expected to begin receiving product in late 2011.
BD is pursuing LEED (Leadership in Energy and Environmental Design) certification for the new building, reflecting the Company’s commitment to environmental stewardship. LEED certification, developed by the U.S. Green Building Council, is the nationally accepted benchmark for the design, construction and operation of high-performance green buildings.
BD currently employs approximately 850 associates in North Carolina, at: BD Technologies in Research Triangle Park; BD Biosciences in Durham; and BD Diagnostics in Burlington, Research Triangle Park and Mebane. BD is also developing a BD Medical facility in Wilson.
BD (bd.com) is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.